Melanocortin 1 Receptor (MC1R): Pharmacological and Therapeutic Aspects
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mun, Yoonwoo | - |
dc.contributor.author | Kim, Woohyun | - |
dc.contributor.author | Shin, Dongyun | - |
dc.date.accessioned | 2023-08-25T08:40:43Z | - |
dc.date.available | 2023-08-25T08:40:43Z | - |
dc.date.created | 2023-08-25 | - |
dc.date.issued | 2023-08 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/88843 | - |
dc.description.abstract | Melanocortins play crucial roles in regulating the stress response, inflammation, and skin pigmentation. In this review, we focus on the melanocortin 1 receptor (MC1R), a G protein-coupled receptor primarily known for regulating skin pigmentation and exhibiting anti-inflammatory effects. First, we provide an overview of the structure, signaling pathways, and related diseases of MC1R. Next, we discuss the potential therapeutic use of synthetic peptides and small molecule modulators of MC1R, highlighting the development of various drugs that enhance stability through amino acid sequence modifications and small molecule drugs to overcome limitations associated with peptide characteristics. Notably, MC1R-targeted drugs have applications beyond skin pigmentation-related diseases, which predominantly affect MC1R in melanocytes. These drugs can also be useful in treating inflammatory diseases with MC1R expression present in various cells. Our review underscores the potential of MC1R-targeted drugs to treat a wide range of diseases and encourages further research in this area. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.title | Melanocortin 1 Receptor (MC1R): Pharmacological and Therapeutic Aspects | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 001045722000001 | - |
dc.identifier.doi | 10.3390/ijms241512152 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.24, no.15 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85167766410 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - |
dc.citation.volume | 24 | - |
dc.citation.number | 15 | - |
dc.contributor.affiliatedAuthor | Mun, Yoonwoo | - |
dc.contributor.affiliatedAuthor | Kim, Woohyun | - |
dc.contributor.affiliatedAuthor | Shin, Dongyun | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | melanocortin | - |
dc.subject.keywordAuthor | receptor | - |
dc.subject.keywordAuthor | peptide | - |
dc.subject.keywordAuthor | modulator | - |
dc.subject.keywordAuthor | disease | - |
dc.subject.keywordPlus | MELANOCYTE-STIMULATING-HORMONE | - |
dc.subject.keywordPlus | PROTEIN-COUPLED RECEPTOR | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | PEPTIDES INHIBIT PRODUCTION | - |
dc.subject.keywordPlus | AGOUTI SIGNALING PROTEIN | - |
dc.subject.keywordPlus | NECROSIS-FACTOR-ALPHA | - |
dc.subject.keywordPlus | MALIGNANT-MELANOMA | - |
dc.subject.keywordPlus | MOLECULAR-CLONING | - |
dc.subject.keywordPlus | SEBACEOUS GLAND | - |
dc.subject.keywordPlus | NITRIC-OXIDE | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.